Boston Scientific Corporation
Boston Scientific Corporation’s Gross Margin at a glance
Boston Scientific Corporation reports gross margin of 61.3% for Dec 2024. The prior period recorded 62% (Dec 2023). Year over year the metric moved −0.71 pts (−1.1%). The rolling three-period average stands at 61.4%. Data last refreshed Dec 18, 2025, 7:58 AM.
Latest reading
61.3% · Dec 2024
YoY movement
−0.71 pts (−1.1%)
Rolling average
61.4%
Current Gross Margin
61.3%
−0.71 pts
−1.1%
Rolling average
61.4%
Latest Value
61.3%
Dec 2024
YoY Change
−0.71 pts
Absolute
YoY Change %
−1.1%
Rate of change
3-Period Avg
61.4%
Smoothed
Narrative signal
Boston Scientific Corporation’s gross margin stands at 61.3% for Dec 2024. Year-over-year, the metric shifted by −0.71 pts, translating into a −1.1% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How gross margin shapes Boston Scientific Corporation's story
As of Dec 2024, Boston Scientific Corporation reports gross margin of 61.3%. Measure pricing power and cost of goods efficiency by reviewing historical gross margins.
Pricing versus input costs
Gross margin expands when pricing power or mix more than offset raw material and labor inflation.
Benchmark to peers
Compare margins within a sector to spot operational advantages or signs of discounting.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Boston Scientific Corporation (BSX) FAQs
Answers tailored to Boston Scientific Corporation’s gross margin profile using the latest Financial Modeling Prep data.
What is Boston Scientific Corporation's current gross margin?
As of Dec 2024, Boston Scientific Corporation reports gross margin of 61.3%. This reading reflects the latest filings and price data for BSX.
How is Boston Scientific Corporation's gross margin trending year over year?
Year-over-year, the figure shifts by −0.71 pts (−1.1%). Pair this context with revenue growth and free cash flow signals to gauge momentum for BSX.
Why does gross margin matter for Boston Scientific Corporation?
Gross margin tracks the percentage of revenue remaining after direct production and service delivery costs. For Boston Scientific Corporation, operating within Healthcare — Medical - Devices, tracking this metric helps benchmark management's execution against close competitors.
Is Boston Scientific Corporation's gross margin above its recent average?
Boston Scientific Corporation's rolling three-period average sits at 61.4%. Comparing the latest reading of 61.3% to that baseline highlights whether momentum is building or fading for BSX.
How frequently is Boston Scientific Corporation's gross margin refreshed?
Data for BSX was last refreshed on Dec 18, 2025, 7:58 AM and updates automatically every 24 hours, keeping your valuation inputs current.